Company
United StatesSurmasis Pharmaceutical, LLC, Des Moines, IA – FDA Inspections
Inspection records and compliance data for Surmasis Pharmaceutical, LLC in Des Moines, Iowa. 3 FDA inspections on record (1 OAI), 2 Form 483s, last inspected August 01, 2025.
Company Profile
This profile covers Surmasis Pharmaceutical, LLC based in Des Moines, Iowa, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 1
- VAI
- 2
- NAI
- 0
- Form 483s
- 2
- Warning letters
- 0
First inspected March 1, 2018. Last inspected August 1, 2025.
Most cited issue areas
- Absence of Written Procedures1 inspection
- Calibration/Inspection/Checking not done1 inspection
- Complete test data included in records1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 1, 2025 | VAI | Human Drugs · Drug Quality Assurance | 1277270 |
| March 19, 2020 | VAI | Human Drugs · Drug Quality Assurance | 1121169 |
| March 1, 2018 | OAI | Human Drugs · Generic Drug Evaluation | 1042777 |
FDA documents
Form 483s (2)
EIRs (1)
People (6)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Surmasis Pharmaceutical, LLC
FEI Number
3011596846
Address
4020 Gannett Ave, Des Moines, Iowa 50321, United States
Country
United States
ID: 6f9dfe3c-c8c3-4740-b9a8-0ecc1bb9b400